Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
None listed
Sponsors
Dr krutika s biradar
Eligibility
Inclusion criteria
Inclusion criteria: Daignosis Subjects with Primary hypertension 1 Age Subjects of age group between 20-40 years 2 Sex: either 3Blood Pressure:Systolic blood pressure: 130-160mmhg Diastolic blood pressure: 80-100mmhg 4Stability: Blood pressure readings stable over 2 weeks ( 10 mmHg variation) 5Subjects who willing to participate and gives written consent
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome parameters to be assessed include improvement in the clinical symptoms of primary hypertension, namely headache, fatigue, dizziness, and palpitation. Secondary outcome parameters include changes in systolic and diastolic blood pressure and overall clinical improvementTimepoint: The outcomes will be assessed at specific time points, namely at baseline, at 0 weekstreatment period 12 weeks followup visits 2 4 8 12 and 16 weeks. The trial drug will be administered for a total duration of 16 weeks, during which periodic assessment will be carried out to evaluate improvement in clinical symptoms of primary hypertension. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: | — |
Countries
India
Contacts
Public ContactDr Krutika s biradar
JAIN AGM AYURVEDIC MEDICAL COLLEGE & HOSPITAL
Outcome results
None listed